Brief: Acer Therapeutics And Relief Therapeutics Announce Submission Of A New Drug Application To The U.S. FDA For Acer-001 For Treatment Of Urea Cycle Disorders

MindMaze Therapeutics Holding SA

09/08/2021 15:21

Aug 9 (Reuters) - Acer Therapeutics Inc  ACER.O :
    * ACER THERAPEUTICS AND RELIEF THERAPEUTICS ANNOUNCE
SUBMISSION OF
A NEW DRUG APPLICATION TO THE U.S. FDA FOR ACER-001 FOR
TREATMENT OF UREA CYCLE DISORDERS
    * ACER THERAPEUTICS AND RELIEF THERAPEUTICS ANNOUNCE
SUBMISSION OF
A NEW DRUG APPLICATION TO THE U.S. FDA FOR ACER-001 FOR
TREATMENT OF UREA CYCLE DISORDERS
    * ACER THERAPEUTICS - RECEIVED AN AGREEMENT LETTER FROM FDA
IN
RESPONSE TO CO'S INITIAL PEDIATRIC STUDY PLAN

Source text for Eikon:  ID:nGNX7Hkcyy 
Further company coverage:  ACER.O 

 ((reuters.briefs@thomsonreuters.com;))